Evidence map›Paper›PMID 37061534›Full record

ArticleScientific reports2023

Trends in SARS-CoV-2 cycle threshold values in the Czech Republic from April 2020 to April 2022.

Dita Musalkova, Lenka Piherova, Ondrej Kwasny, Zuzana Dindova, Lubor Stancik, Hana Hartmannova, Otomar Slama, Petra Peckova, Josef Pargac, Gabriel Minarik and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dita Musalkova *Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Lenka Piherova *Research Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Ondrej Kwasny *SPADIA LAB, Ostrava, Czech Republic.
Zuzana DindovaSPADIA LAB, Ostrava, Czech Republic.
Lubor StancikSPADIA LAB, Ostrava, Czech Republic.
Hana HartmannovaResearch Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Otomar SlamaFaculty of Safety Engineering, Technical University of Ostrava, Ostrava, Czech Republic.
Petra PeckovaRegional Authority of the Central Bohemia Region, Prague, Czech Republic.
Josef PargacSPADIA LAB, Ostrava, Czech Republic.
Gabriel MinarikMedirex Group Academy, Trnava, Slovakia.
Tomas ZimaInstitute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and the First Faculty of Medicine of Charles University, Prague, Czech Republic.
Anthony J BleyerResearch Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Martin RadinaSPADIA LAB, Ostrava, Czech Republic.
Michal PohludkaGeneSpector, Prague, Czech Republic.
Stanislav KmochResearch Unit of Rare Diseases, Department of Paediatric and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. skmoch@lf1.cuni.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inability to predict the evolution of the COVID-19 epidemic hampered abilities to respond to the crisis effectively. The cycle threshold (Ct) from the standard SARS-CoV-2 quantitative reverse transcription-PCR (RT-qPCR) clinical assay is inversely proportional to the amount of SARS-CoV-2 RNA in the sample. We were interested to see if population Ct values could predict future increases in COVID-19 cases as well as subgroups that would be more likely to be affected. This information would have been extremely helpful early in the COVID-19 epidemic. We therefore conducted a retrospective analysis of demographic data and Ct values from 2,076,887 nasopharyngeal swab RT-qPCR tests that were performed at a single diagnostic laboratory in the Czech Republic from April 2020 to April 2022 and from 221,671 tests that were performed as a part of a mandatory school surveillance testing program from March 2021 to March 2022. We found that Ct values could be helpful predictive tools in the real-time management of viral epidemics. First, early measurement of Ct values would have indicated the low viral load in children, equivalent viral load in males and females, and higher viral load in older individuals. Second, rising or falling median Ct values and differences in Ct distribution indicated changes in the transmission in the population. Third, monitoring Ct values and positivity rates would have provided early evidence as to whether prevention measures are effective. Health system authorities should thus consider collecting weekly median Ct values of positively tested samples from major diagnostic laboratories for regional epidemic surveillance.

Indexed as

COVID-19SARS-CoV-2AgedChildCzech RepublicFemaleHumansMaleRetrospective StudiesRNA, ViralViral LoadRNA, Viral

Identifiers

PMID37061534
PMCPMC10105352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.